Allspring Global Investments Holdings LLC Reduces Position in DaVita Inc. (NYSE:DVA)

Allspring Global Investments Holdings LLC cut its stake in DaVita Inc. (NYSE:DVA) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,041 shares of the company’s stock after selling 88 shares during the period. Allspring Global Investments Holdings LLC’s holdings in DaVita were worth $306,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC acquired a new position in DaVita in the 3rd quarter worth $25,000. Blue Trust Inc. lifted its holdings in shares of DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after buying an additional 119 shares during the period. Quarry LP bought a new stake in shares of DaVita during the 3rd quarter worth $60,000. Versant Capital Management Inc lifted its position in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Wingate Wealth Advisors Inc. acquired a new stake in DaVita during the 4th quarter worth about $82,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of DVA opened at $143.08 on Wednesday. DaVita Inc. has a fifty-two week low of $124.42 and a fifty-two week high of $179.60. The company’s 50-day moving average is $160.77 and its 200-day moving average is $158.21. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The firm has a market capitalization of $11.45 billion, a PE ratio of 13.32, a PEG ratio of 1.07 and a beta of 0.93.

DaVita (NYSE:DVA) last released its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $162.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.